American Well (AMWL) Expected to Announce Quarterly Earnings on Tuesday

American Well (NYSE:AMWL) is anticipated to announce its Q2 2025 earnings results after the market closes on Tuesday, August 5th. Analysts expect the company to announce earnings of ($1.90) per share and revenue of $63.87 million for the quarter.

American Well (NYSE:AMWL) last issued its earnings results on Thursday, May 1st. The company reported ($1.73) earnings per share for the quarter, topping the consensus estimate of ($3.09) by $1.36. American Well had a negative return on equity of 48.36% and a negative net margin of 59.13%. The company had revenue of $66.83 million during the quarter, compared to the consensus estimate of $60.15 million. On average, analysts expect American Well to post $-9 EPS for the current fiscal year and $-6 EPS for the next fiscal year.

American Well Price Performance

Shares of NYSE AMWL opened at $6.90 on Friday. American Well has a 1-year low of $6.09 and a 1-year high of $12.95. The business has a 50-day moving average of $7.67 and a 200-day moving average of $8.33. The company has a market capitalization of $107.71 million, a price-to-earnings ratio of -0.68 and a beta of 1.28.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on AMWL. UBS Group reduced their price target on American Well from $12.00 to $9.00 and set a “neutral” rating for the company in a report on Thursday, May 8th. Stifel Nicolaus decreased their target price on American Well from $10.00 to $8.00 and set a “hold” rating for the company in a research report on Friday, May 2nd. Needham & Company LLC reiterated a “hold” rating on shares of American Well in a report on Friday, May 2nd. Piper Sandler reiterated a “neutral” rating and issued a $8.00 price target (down from $10.00) on shares of American Well in a report on Friday, May 23rd. Finally, Truist Financial lowered their price target on American Well from $12.00 to $7.50 and set a “hold” rating for the company in a report on Thursday, April 10th. Six research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $9.67.

Insider Activity

In related news, insider Phyllis Gotlib sold 4,958 shares of American Well stock in a transaction dated Tuesday, July 1st. The stock was sold at an average price of $8.63, for a total value of $42,787.54. Following the transaction, the insider owned 136,891 shares of the company’s stock, valued at approximately $1,181,369.33. This trade represents a 3.50% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In the last 90 days, insiders sold 10,184 shares of company stock worth $78,000. 11.82% of the stock is currently owned by company insiders.

Institutional Trading of American Well

An institutional investor recently raised its position in American Well stock. Jane Street Group LLC boosted its position in shares of American Well Corporation (NYSE:AMWL) by 232.9% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 64,112 shares of the company’s stock after purchasing an additional 44,852 shares during the period. Jane Street Group LLC owned 0.41% of American Well worth $505,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 56.05% of the company’s stock.

About American Well

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.